|
"peng cheng yuan"的相關文件
顯示項目 31-55 / 71 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T04:44:45Z |
An External Loop Region of Domain III of Dengue Virus Type 2 Envelope Protein Is Involved in Serotype-Specific Binding to Mosquito but Not Mammalian Cells
|
Wang, Ying-Bin; Peng, Cheng-Yuan; Zhang, Jun; Kao, Jia-Horng; Chen, Ding-Shinn; Chen, Pei-Jer; Xia, Ning-Shao; ���w�H; ���ŧ�; �B�T�H; ������; Ge, Sheng-Xiang; Hung, Jan-Jong; Hsieh, Meng-Ti; Young, Ming-Jer; Kao, Chuan-Liang; King, Chwan-Chuen; Chang, Wen; Hung, JJ;Hsieh, MT;Young, MJ;Kao, CL;King, CC;Chang, W.; Hung, J.-J. and Hsieh, M.-T. and Young, M.-J. and Kao, C.-L. and King, C.-C. and Chang, W.; Hung, Jan-Jong; CHUAN-LIANG KAO; Yuan, Quan; Hung, JJ; Hsieh, MT; Hsieh, Meng-Ti; Song, Liu-Wei; Young, Ming-Jer; Liu, Chun-Jen; Young, MJ; Li, Zhuo; Kao, Chuan-Liang; Kao, CL; King, CC; King, Chwan-Chuen; Liu, Ping-Guo; Chang, Wen; Huang, Cheng-Hao; Chang, W.; Yan, Yan |
| 國立成功大學 |
2016-11 |
Asian patients with hepatitis C (HCV) genotype 1 treated with ledipasvir and sofosbuvir (LDV/SOF) experience very high efficacy and improvement of health-related quality of life (HRQL)
|
Younossi, Zobair; Stepanova, Maria; Han, Kwang-Hyub; Lim, Young-Suk; Lee, Youn-Jae; Chuang, Wan-Long; Kao, Jia-Horng; Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan |
| 國立成功大學 |
2016-10 |
Comparison of Health-Related Quality of Life (HRQL) in Asian Patients with Chronic Hepatitis C Treated with Interferon (IFN)-free Ribavirin (RBV)-Containing Regimens vs Interferon-free and Ribavirin-free Regimens
|
Younossi, Zobair M.;Stepanova, Maria;Han, Kwang-Hyub;Chuang, Wan-Long;Chan, Henry Lik-Yuen;Lim, Young-Suk;Chien, Rong-Nan;Ahn, Sang Hoon;Jeong, Sook-Hyang;Chang, Ting-Tsung;Paik, Seung Woon;Peng, Cheng-Yuan;Chu, Chi-Jen;Lee, Youn-Jae;Lai, Ching-Lung;Kao, Jia-Horng;Hunt, Sharon |
| 國立成功大學 |
2016-10 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie |
| 國立成功大學 |
2016-08 |
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
|
Kao, Jia-Horng;Chien, Rong-Nan;Chang, Ting-Tsung;Peng, Cheng-Yuan;Hu, Tsung-Hui;Lo, Gin-Ho;Wang, Horng-Yuan;Chen, Jyh-Jou;Yang, Jenny C.;Knox, Steven J.;Han, Lingling;Mo, Hongmei;Mathias, Anita;Brainard, Diana M.;Sheen, I-Shyan;Hsu, Yu-Chun;Chu, Chi-Jen;Chuang, Wan-Long |
| 國立成功大學 |
2016-07 |
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
|
Chuang, Wan-Long;Chien, Rong-Nan;Peng, Cheng-Yuan;Chang, Ting-Tsung;Lo, Gin-Ho;Sheen, I-Shyan;Wang, Horng-Yuan;Chen, Jyh-Jou;Yang, Jenny C.;Knox, Steven J.;Gao, Bing;Garrison, Kimberly L.;Mo, Hongmei;Pang, Phillip S.;Hsu, Yu-Chun;Hu, Tsung-Hui;Chu, Chi-Jen;Kao, Jia-Horng |
| 國立成功大學 |
2016-05 |
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)
|
Chan, Henry L. Y.;Ahn, Sang Hoon;Chang, Ting-Tsung;Peng, Cheng-Yuan;Wong, David;Coffin, Carla S.;Lim, Seng Gee;Chen, Pei-Jer;Janssen, Harry L. A.;Marcellin, Patrick;Serfaty, Lawrence;Zeuzem, Stefan;Cohen, David;Critelli, Linda;Xu, Dong;Wind-Rotolo, Megan;Cooney, Elizabeth |
| 國立臺灣大學 |
2016 |
Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis
|
Kao, Jia-Horng; Jensen, Donald M.; Manns, Michael P.; Jacobson, Ira; Kumada, Hiromitsu; Toyota, Joji; Heo, Jeong; Yoffe, Boris; Sievert, William; Bessone, Fernando; Peng, Cheng-Yuan; Roberts, Stuart K.; Lee, Youn-Jae; Bhore, Rafia; Mendez, Patricia; Hughes, Eric; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2016 |
A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection
|
Kao, Jia-Horng; Chien, Rong-Nan; Chang, Ting-Tsung; Peng, Cheng-Yuan; Hu, Tsung-Hui; Lo, Gin-Ho; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Han, Lingling; Mo, Hongmei; Mathias, Anita; Brainard, Diana M.; Sheen, I-Shyan; Hsu, Yu-Chun; Chu, Chi-Jen; Chuang, Wan-Long; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus
|
Chuang, Wan-Long; Chien, Rong-Nan; Peng, Cheng-Yuan; Chang, Ting-Tsung; Lo, Gin-Ho; Sheen, I-Shyan; Wang, Horng-Yuan; Chen, Jyh-Jou; Yang, Jenny C.; Knox, Steven J.; Gao, Bing; Garrison, Kimberly L.; Mo, Hongmei; Pang, Phillip S.; Hsu, Yu-Chun; Hu, Tsung-Hui; Chu, Chi-Jen; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
All-oral daclatasvir plus asunaprevir for chronic hepatitis C virus (HCV) genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study
|
Kao, Jia-Horng; Lee, Youn-Jae; Heo, Jeong; Ahn, Sang-Hoon; Lim, Young-Suk; Peng, Cheng-Yuan; Chang, Ting-Tsung; Torbeyns, Anne; Hughes, Eric; Bhore, Rafia; Noviello, Stephanie; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Efficacy of entecavir therapy for hepatitis B e-antigen positive chronic hepatitis B patients with prior exposure to interferon or nucleoside/nucleotide analogues
|
Tseng, Kuo-Chih; Tseng, Chih-Wei; Hsieh, Tsai-Yuan; Peng, Cheng-Yuan; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi; Lin, Chih-Lin; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Peng, Cheng-Yuan; Su, Tung-Hung; Yang, Sheng-Shun; Hsu, Yu-Chun; Chen, Tsung-Ming; Kao, Jia-Horng; 高嘉宏; 蘇東弘 |
| 國立臺灣大學 |
2016 |
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Bair, Ming-Jong; Liang, Cheng-Chao; Lei, Yung-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立高雄第一科技大學 |
2015/05/22 |
偏態、峰態與非對稱系統性風險對股票報酬率之影響
|
彭政元; Peng, Cheng-Yuan |
| 國立成功大學 |
2015-09-14 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung |
| 國立臺灣大學 |
2015 |
Distinct viral evolution and quasispecies dynamics between hepatitis B e antigen seroconverters and non-seroconverters in response to interferon-based therapy
|
Yang, Hung-Chih; Lin, Su-Ru; Liu, Chun-Jen; Peng, Cheng-Yuan; Tseng, Tai-Chung; Su, Tung-Hung; Chen, Pei-Jer; Kao, Jia-Horng; 高嘉宏; 楊宏志; 蘇東弘; 劉俊人; 陳培哲 |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
|
Yang, Chi-Chieh; Tsai, Wei-Lun; Su, Wei-Wen; Huang, Chung-Feng; Cheng, Pin-Nan; Lo, Ching-Chu; Tseng, Kuo-Chih; Mo, Lein-Ray; Wang, Chun-Hsiang; Hsu, Shih-Jer; Lai, Hsueh-Chou; Su, Chien-Wei; Liu, Chun-Jen; Peng, Cheng-Yuan; Yu, Ming-Lung; 徐士哲; 劉俊人 |
| 國立臺灣大學 |
2015 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy-The final report of C-TEAM study
|
Su, Tung-Hung; Hu, Tsung-Hui; Chen, Chi-Yi; Huang, Yi-Hsiang; Chuang, Wan-Long; Lin, Chun-Che; Wang, Chia-Chi; Su, Wei-Wen; Chen, Ming-Yao; Peng, Cheng-Yuan; Chien, Rong-Nan; Huang, Yi-Wen; Wang, Horng-Yuan; Lin, Chih-Lin; Yang, Sheng-Shun; Chen, Tsung-Ming; Mo, Lein-Ray; Hsu, Shih-Jer; Tseng, Kuo-Chih; Hsieh, Tsai-Yuan; Suk, Fat-Moon; Hu, Chi-Tan; Ming-Jong, Bair; Liang, Cheng-Chao; Tseng, Tai-Chung; Chen, Chi-Ling; Kao, Jia-Horng; 高嘉宏; 蘇東弘; 徐士哲; 陳祈玲 |
| 國立臺灣大學 |
2015 |
Benefits of Antiviral Treatment and Predictors of Subsequent Hepatocellular Carcinoma Risk in Chronic Hepatitis C Patients with or without Sustained Virological Response to Peg-interferon plus Ribavirin Therapy
|
Lee, Mei-Hsuan; Lu, Sheng-Nan; Yu, Ming-Lung; Peng, Cheng-Yuan; Sheen, I-Shyan; Liu, Chen-Hua; Kao, Jia-Horng; Chuang, Wan-Long; Yang, Hwai-I; L'Italien, Gilbert; Yuan, Yong; Chen, Chien-Jen; 劉振驊; 高嘉宏 |
| 國立成功大學 |
2014-11-01 |
All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study
|
Manns, Michael; Pol, Stanislas; Jacobson, Ira M.; Marcellin, Patrick; Gordon, Stuart C.; Peng, Cheng-Yuan; Chang, Ting-Tsung; Everson, Gregory T.; Heo, Jeong; Gerken, Guido; Yoffe, Boris; Towner, William J.; Bourliere, Marc; Metivier, Sophie; Chu, Chi-Jen; Sievert, William; Bronowicki, Jean-Pierre; Thabut, Dominique; Lee, Youn-Jae; Kao, Jia-Horng; McPhee, Fiona; Kopit, Justin; Mendez, Patricia; Linaberry, Misti; Hughes, Eric; Noviello, Stephanie |
| 國立成功大學 |
2014-08-28 |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu, Chun-Jen; Chang, Juliana; Lee, Po-Huang; Lin, Deng-Yn; Wu, Cheng-Chung; Jeng, Long-Bin; Lin, Yih-Jyh; Mok, King-Tong; Lee, Wei-Chen; Yeh, Hong-Zen; Ho, Ming-Chih; Yang, Sheng-Shun; Yang, Mei-Due; Yu, Ming-Chin; Hu, Rey-Heng; Peng, Cheng-Yuan; Lai, Kuan-Lang; Chang, Stanley Shi-Chung; Chen, Pei-Jer |
| 臺北醫學大學 |
2014 |
Reduction of hepatocellular carcinoma in hepatitis B-related cirrhosis patients with long-term entecavir therapy - A follow-up report of C-TEAM study
|
Su, Tung-Hung;Hu, Tsung-Hui;Chen, Chi-Yi;Huang, Yi-Hsiang;Chuang, Wan-Long;Lin, Chun-Che;Wang, Chia-Chi;Su, Wei-Wen;Peng, Cheng-Yuan;Chien, Rong-Nan;Mo, Lein-Ray;Huang, Yi-Wen;Chen, Ming-Yao;Lin, Chih-Lin;Chen, Tsung-Ming;Wang, Horng-Yuan;Tseng, Kuo-Chih;Yang, Sheng-Shun;Hsu, Shih-Jer;Suk, Fat-Moon;Hu, Chi-Tan;Hsieh, Tsai-Yuan;Ming-jong, Bair;Liang, Cheng-Chao;Tseng, Tai-Chung;Chen, Chi-Ling;Kao, Jia-Horng |
| 國立臺灣大學 |
2014 |
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naive Taiwanese patients with chronic hepatitis B
|
Chien, Rong-Nan; Peng, Cheng-Yuan; Kao, Jia-Horng; Hu, Tsung-Hui; Lin, Chun-Che; Hu, Chi-Tan; Chen, Chi-Yi; Hsieh, Tsai-Yuan; Lin, Han-Chieh; Chuang, Wan-Long; 高嘉宏 |
顯示項目 31-55 / 71 (共3頁)
<< < 1 2 3 > >>
每頁顯示[10|25|50]項目
|
